Saha Shamoli, Sultana Sharmin, Rahmat Raad, Akther Tahmina, Nessa Ashrafun, Jahan Munira
Department of Virology, Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh.
MTLS Program, Karolinska Institute, Stockholm, Sweden.
Clin Med Insights Oncol. 2025 Mar 25;19:11795549251316767. doi: 10.1177/11795549251316767. eCollection 2025.
Cervical cancer is the second most common cancer in Bangladesh and is primarily caused by persistent high-risk human papillomavirus (HR-HPV) infection. Several risk factors, including immunological, genetic, environmental, and viral factors, may contribute to the development of cervical cancer. Moreover, a disruption in an otherwise delicate balance between immune response and cytokine production may lead to diseased states. Henceforth, this study aimed to determine and compare selected cytokines, including interleukin-6 (IL-6), interleukin-1 beta (IL-1β), tumor necrosis factor-alpha (TNF-α), interferon-gamma (INF-γ), interleukin-10 (IL-10), GM-CSF, interleukin-8 (IL-8), and MCP-1 among HR-HPV-infected patients with cervical cancer, precancer individuals, and healthy participants to test the propensity of these cytokines to serve as predictive biomarkers for the detection of cervical cancer during its early stages.
A cross-sectional study was conducted on female patients visiting two referral hospitals in Bangladesh from September to November 2022. Among them, 80 women were enrolled in the study as patients with cervical cancer and precancerous lesions along with HPV DNA-negative healthy individuals. The selected cytokines in the cervical swab were estimated by flow cytometry.
Cervical cancer and precancer were primarily detected in patients aged above 40 years (73.3% and 46.7% of the patients in the respective groups). Other significant risk factors, including poor educational, socioeconomic status and nutritional conditions, age of first coitus, multiparity, and tobacco and betel nut consumption, were found significant for the development of cervical cancer and precancer ( < .05). The levels of IL-6, IL-1β, IL-10, IL-8, and MCP-1 were substantially elevated in patients with cancer than in patients with precancer and healthy individuals ( < .001). Moreover, the levels of IL-6, IL-1β, IL-10, and IL-8 were also significantly increased in patients with precancer than in healthy individuals ( < .05).
Thus, IL-6, IL-1β, IL-10, IL-8, and MCP-1 can be used as potential biomarkers for diagnostic and prognostic purposes in HPV-induced cervical cancer and precancer.
宫颈癌是孟加拉国第二常见的癌症,主要由持续性高危型人乳头瘤病毒(HR-HPV)感染引起。包括免疫、遗传、环境和病毒因素在内的多种风险因素可能导致宫颈癌的发生。此外,免疫反应和细胞因子产生之间原本微妙的平衡被打破可能会导致疾病状态。因此,本研究旨在测定和比较部分细胞因子,包括白细胞介素-6(IL-6)、白细胞介素-1β(IL-1β)、肿瘤坏死因子-α(TNF-α)、干扰素-γ(INF-γ)、白细胞介素-10(IL-10)、粒细胞-巨噬细胞集落刺激因子(GM-CSF)、白细胞介素-8(IL-8)和单核细胞趋化蛋白-1(MCP-1),在HR-HPV感染的宫颈癌患者、癌前病变个体和健康参与者中的水平,以测试这些细胞因子作为早期宫颈癌检测预测生物标志物的可能性。
于2022年9月至11月对前往孟加拉国两家转诊医院就诊的女性患者进行了一项横断面研究。其中,80名女性作为宫颈癌和癌前病变患者以及HPV DNA阴性的健康个体被纳入研究。通过流式细胞术测定宫颈拭子中选定的细胞因子。
宫颈癌和癌前病变主要在40岁以上的患者中检出(各相应组中分别为73.3%和46.7%的患者)。其他显著的风险因素,包括教育程度低、社会经济地位和营养状况差、首次性交年龄、多产以及吸烟和嚼槟榔,被发现与宫颈癌和癌前病变的发生显著相关(P<0.05)。癌症患者中IL-6、IL-1β、IL-10、IL-8和MCP-1的水平显著高于癌前病变患者和健康个体(P<0.001)。此外,癌前病变患者中IL-6、IL-1β、IL-10和IL-8的水平也显著高于健康个体(P<0.05)。
因此,IL-6、IL-1β、IL-10、IL-8和MCP-1可作为HPV诱导的宫颈癌和癌前病变诊断和预后的潜在生物标志物。